YOOJU JUNG

Dr. YOOJU JUNG

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YKYong Joon Kim
Yong Joon Kim
SKSungsoo Kim
Sungsoo Kim
YJYOOJU JUNG
YOOJU JUNG
EJEunji Jung
Eunji Jung
HKHo Jeong Kwon
Ho Jeong Kwon
JKJoon Kim
Joon Kim
Ciliopathies are clinically overlapping genetic disorders involving structural and functional abnormalities of cilia. Currently, there are no small-molecule drugs available to treat ciliary defects in ciliopathies. Our phenotype-based screen identified the flavonoid eupatilin and its analogs as lead compounds for developing ciliopathy medication. CEP290, a gene mutated in several ciliopathies, encodes a protein that forms a complex with NPHP5 to support the function of the ciliary transition zone. Eupatilin relieved ciliogenesis and ciliary receptor delivery defects resulting from deletion of CEP290. In rd16 mice harboring a blinding Cep290 in-frame deletion, eupatilin treatment improved both opsin transport to the photoreceptor outer segment and electrophysiological responses of the retina to light stimulation. The rescue effect was due to eupatilin-mediated inhibition of calmodulin binding to NPHP5, which promoted NPHP5 recruitment to the ciliary base. Our results suggest that deficiency of a ciliopathy protein could be mitigated by small-molecule compounds that target other ciliary components that interact with the ciliopathy protein.

1 February 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YJYOOJU JUNG
YOOJU JUNG
SCSung Min Cho
Sung Min Cho
SKSungsoo Kim
Sungsoo Kim
JCJae-Ho Cheong
Jae-Ho Cheong
HKHo Jeong Kwon
Ho Jeong Kwon

5 April 2022 in Clinical and Translational Medicine
Verified
Journal Article
Open access
YJYOOJU JUNG
YOOJU JUNG
SLSeung-Eun Lee
Seung-Eun Lee
IKInsung Kang
Insung Kang
SCSung Min Cho
Sung Min Cho
KKKyung-Sun Kang
Kyung-Sun Kang
HKHo Jeong Kwon
Ho Jeong Kwon

19 March 2026 in Biology
Verified
Journal Article
Open access
PDF file
JKJonghun Kim
Jonghun Kim
YJYoon Sun Jang
Yoon Sun Jang
MLMinseong Lee
Minseong Lee
NCNa Young Choi
Na Young Choi
YJYOOJU JUNG
YOOJU JUNG
TKTae Hwan Kwak
Tae Hwan Kwak
The human cerebral cortex is organized into distinct area-specific regions along the rostral–caudal axis, yet current human brain organoid models incompletely recapitulate this regional diversity. Here, we establish an area-specific brain organoid platform by leveraging transcription factors (TFs) identified through re-analysis of in vivo human cortical transcriptomic datasets. Publicly available single-cell RNA sequencing datasets from human developing cortex were re-analyzed to identify differentially expressed genes associated with rostral and caudal cortical identities. From this analysis, we identified SP9 (rostral-enriched) and DMRTA2 (caudal-enriched) as candidate TFs governing regional specification. To model cortical area identity, these TFs were overexpressed in an inducible manner during human cerebral organoid (hCO) generation. Overexpression of SP9 resulted in hCOs exhibiting rostral cortical characteristics, whereas DMRTA2 overexpression promoted caudal cortical features. The resulting hCOs showed distinct regional identities, reflected by differential expression of area-specific markers. In addition, these regional identities were accompanied by distinct functional phenotypes, as calcium imaging revealed divergent patterns of spontaneous neural activity between rostral and caudal hCOs. Altogether, our findings demonstrate that overexpression of TFs enables the controlled generation of area-specific hCOs. This approach provides a scalable and reproducible platform for studying human cortical regionalization and offers a framework for investigating region-specific mechanisms underlying neurodevelopmental and neurological disorders.